Can Continuous positive airway pressure reduce the risk of stroke in obstructive sleep apnea patients? A systematic review and meta-Analysis

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Kim, Yeshin ^a   Koo, Yong Seo ^b   Lee, Hee Young ^c   Lee, Seo Young ^a  

^a Kangwon National University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; TREATMENT OUTCOME; COMPLICATION; PATHOPHYSIOLOGY; RISK; SLEEP APNEA, OBSTRUCTIVE; STROKE;

CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INCIDENCE; RISK; SLEEP APNEA, OBSTRUCTIVE; STROKE;

EID: 84953776490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146317     Document Type: Article

References (34)

1. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: An american heart association/american college of cardiology foundation scientific statement from the american heart association council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing in collaboration with the national heart, lung, and blood institute national center on sleep disorders research (national institutes of health). Journal of the American College of Cardiology. 2008; 52 (8):686-717. doi: 10.1016/j.jacc.2008.05.002
2. Peter B, Ronald G. Positive Airway Pressure Treatment for Obstructive Sleep Apnea-Hypopnea Syndrome. In: Meir H K, Thomas R, William C. D, editors. Principles and Practice of Sleep Medicine. 5th ed: Saunders; 2011. p. 1233-49.
3. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007; 50(2):417-23.
4. Benjamin JA, Lewis K. Sleep-disordered breathing and cardiovascular disease. Postgraduate medical journal. 2008; 84(987):15-22. doi: 10.1136/pgmj.2007.062836
5. Kasai T, Floras JS, Bradley TD. Sleep Apnea and Cardiovascular Disease A Bidirectional Relationship. Circulation. 2012; 126(12):1495-510. doi: 10.1161/CIRCULATIONAHA.111.070813
6. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. New England Journal of Medicine. 2005; 353(19):2034-41.
7. Loke YK, Brown JWL, Kwok CS, Niruban A, Myint PK. Association of Obstructive Sleep Apnea With Risk of Serious Cardiovascular Events A Systematic Review and Meta-Analysis. Circulation: Cardiovascular Quality and Outcomes. 2012; 5(5):720-8.
8. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-Term prognosis. American Journal of Respiratory and Critical Care Medicine. 2001; 164(10):1910-3.
9. Elwood P, Hack M, Pickering J, Hughes J, Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. Journal of epidemiology and community health. 2006; 60 (1):69-73.
10. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45 (7):2160-236. doi: 10.1161/STR.0000000000000024
11. Birkbak J, Clark AJ, Rod NH. The effect of sleep disordered breathing on the outcome of stroke and transient ischemic attack: A systematic review. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2014; 10(1):103.
12. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(1):227-76. doi: 10.1161/STR.0b013e3181f7d043
13. Parra O, Sánchez-Armengol A, Bonnin M, Arboix A, Campos-Rodríguez F, Pérez-Ronchel J, et al. Early treatment of obstructive apnoea and stroke outcome: A randomised controlled trial. European Respiratory Journal. 2011; 37(5):1128-36. doi: 10.1183/09031936.00034410
14. Martínez-García M, Campos-Rodríguez F, Soler-Cataluña J, Catalán-Serra P, Román-Sánchez P, Montserrat J. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment. European Respiratory Journal. 2012; 39(4):906-12. doi: 10.1183/09031936.00011311
15. Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke diagnosis, risk factors, treatment, evolution, and long-Term clinical outcome. Stroke. 2006; 37(4):967-72.
16. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(2):517-84. doi: 10.1161/STR.0b013e3181fcb238
17. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: The PRISMA statement. Annals of internal medicine. 2009; 151(4):264-9.
18. Higgins JP, Altman DG, Gøtzsche PC, Jöni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 2011;343.
19. Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. Journal of clinical epidemiology. 2013; 66(4):408-14. doi: 10.1016/j.jclinepi.2012.09.016
20. Higgins JPT GSe. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available: www.cochrane-handbook.org.
21. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: A randomized controlled trial. Jama. 2012; 307(20):2161-8. doi: 10.1001/jama.2012.4366
22. Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-Term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. CHEST Journal. 2005; 127 (6):2076-84.
23. Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. American Journal of Respiratory and Critical Care Medicine. 2007; 176(12):1274-80.
24. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: A cohort study. Annals of internal medicine. 2012; 156(2):115-22. doi: 10.7326/0003-4819-156-2-201201170-00006
25. Martínez-García M-A, Campos-Rodríguez F, Catalán-Serra P, Soler-Cataluña J-J, Almeida-Gonzalez C, De la Cruz Morón I, et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-Term continuous positive airway pressure treatment: A prospective observational study. American journal of respiratory and critical care medicine. 2012; 186(9):909-16. doi: 10.1164/rccm.201203-0448OC
26. Campos-Rodriguez F, Martinez-Garcia MA, Reyes-Nuñez N, Caballero-Martinez I, Catalan-Serra P, Almeida-Gonzalez CV. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. American Journal of Respiratory and Critical Care Medicine. 2014; 189(12):1544-50. doi: 10.1164/rccm.201311-2012OC
27. Lamberts M, Nielsen O, Lip G, Ruwald MH, Christiansen CB, Kristensen SL, et al. Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. Journal of internal medicine. 2014; 276(6):659-66. doi: 10.1111/joim.12302
28. Molnar MZ, Mucsi I, Novak M, Szabo Z, Freire AX, Huch KM, et al. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax. 2015:thoraxjnl-2015-206970.
29. Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep. 2008; 31(9):1207.
30. Yaggi H, Mohsenin V. Sleep-disordered breathing and stroke. Clinics in chest medicine. 2003; 24 (2):223-37.
31. Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O'Connor GT, Resnick HE, et al. Obstructive sleep apnea-hypopnea and incident stroke: The sleep heart health study. American Journal of Respiratory and Critical Care Medicine. 2010; 182(2):269-77. doi: 10.1164/rccm.200911-1746OC
32. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure the sleep heart health study. Circulation. 2010; 122(4):352-60. doi: 10.1161/CIRCULATIONAHA.109.901801
33. Lavie P. Mortality in sleep apnoea syndrome: A review of the evidence. European Respiratory Review. 2007; 16(106):203-10.
34. Montserrat JM, Ferrer M, Hernandez L, Farre RN, Vilagut G, Navajas D, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: A randomized controlled study with an optimized placebo. American Journal of Respiratory and Critical Care Medicine. 2001; 164(4):608-13.